CABA
Cabaletta Bio, Inc. - Common Stock (CABA)
$55
About Cabaletta Bio, Inc. - Common Stock (CABA)
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Details
Daily high
$2.61
Daily low
$2.52
Price at open
--
52 Week High
$4.23
52 Week Low
$2.00
Market cap
432.3M
Dividend yield
-
Volume
405
Avg. volume
5.6M
P/E ratio
-1.61
Cabaletta Bio, Inc. - Common Stock News
Details
Daily high
$2.61
Daily low
$2.52
Price at open
--
52 Week High
$4.23
52 Week Low
$2.00
Market cap
432.3M
Dividend yield
-
Volume
405
Avg. volume
5.6M
P/E ratio
-1.61